Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function

Inflammatory Bowel Diseases

Volumn 17, Issue 11, 2011, Pages 2235-2250

  Ueno, Nobuhiro ^a   Fujiya, Mikihiro ^a   Segawa, Shuichi ^b   Nata, Toshie ^a   Moriichi, Kentaro ^a   Tanabe, Hiroki ^a   Mizukami, Yusuke ^a   Kobayashi, Naoyuki ^b   Ito, Kazutoshi ^b   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b SAPPORO BREWERIES LTD   (Japan)

Author keywords

barrier function; heat shock protein; IL 1 ; IL 12; Lactobacillus brevis; p38MAPK; proinflammatory cytokines; TNF

Indexed keywords

HEAT SHOCK PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INTESTINE FUNCTION; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS BREVIS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY BARRIER; PRIORITY JOURNAL; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COLITIS; DEXTRAN SULFATE; HOT TEMPERATURE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTESTINAL DISEASES; LACTOBACILLUS BREVIS; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054760125     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21597     Document Type: Article

References (65)

1. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001; 291: 881-884. (Pubitemid 32120760)
2. Simon GL, Gorbach SL,. Intestinal flora in health and disease. Gastroenterology. 1984; 86: 174-193. (Pubitemid 14177335)
3. Borriello SP,. Microbial flora of the gastrointestinal tract. In:, Hill MJ, ed. Microbial Metabolism in the Digestive Tract. Boca Raton, FL: CRC Press; 1986: 2-16.
4. Bengmark S,. Ecological control of the gastrointestinal tract: the role of probiotic flora. Gut. 1998; 42: 2-7. (Pubitemid 28228378)
5. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997; 159: 1739-1745. (Pubitemid 127484159)
6. Guarner F, Schaafsma G,. Probiotics. Int J Food Microbiol. 1998; 39: 237-238. (Pubitemid 28132640)
7. Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun. 1997; 65: 4165-4172. (Pubitemid 27422074)
8. Alak JI, Wolf BW, Mdurvwa EG, et al. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome. J Infect Dis. 1997; 175: 218-221. (Pubitemid 27020853)
9. Hamilton-Miller JM,. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents. 2003; 22: 360-366. (Pubitemid 37163724)
10. Goldin BR, Gualtieri LJ, Moore RP,. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr Cancer. 1996; 25: 197-204.
11. Lee YK, Puong KY, Ouwehand AC, et al. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol. 2003; 52: 925-930. (Pubitemid 37297325)
12. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001; 121: 580-591. (Pubitemid 32822573)
13. Malin M, Suomalainen H, Saxelin M, et al. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab. 1996; 40: 137-145. (Pubitemid 26335799)
14. Lee YK, Lim CY, Teng WL, et al. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol. 2000; 66: 3692-3697.
15. Tao Y, Drabik KA, Waypa TS, et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol. 2006; 290: C1018-1030.
16. Cleveland J, Montville TJ, Nes IF, et al. Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2001; 71: 1-20. (Pubitemid 33065596)
17. Fujiya M, Musch MW, Nakagawa Y, et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe. 2007; 1: 299-308. (Pubitemid 46865606)
18. Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007; 13: 35-37. (Pubitemid 46067383)
19. Kruis W, Schutz E, Fric P, et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 1997; 11: 853-858.
20. Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999; 354: 635-639. (Pubitemid 29391428)
21. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000; 119: 305-309. (Pubitemid 30621980)
22. Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004; 20: 1133-1141. (Pubitemid 39657947)
23. Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005; 100: 1539-1546. (Pubitemid 41032360)
24. Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii-a prospective-study. Gastroenterology. 1989; 96: 981-988. (Pubitemid 19091110)
25. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994; 271: 1913-1918. (Pubitemid 24177098)
26. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005; 147: 192-196. (Pubitemid 41207832)
27. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008; 122: 693-700.
28. McFarland LV,. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006; 101: 812-822.
29. Rahimi R, Nikfar S, Rahimi F, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci. 2008; 53: 2524-2531.
30. Segawa S, Wakita Y, Hirata H, et al. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice. Int J Food Microbiol. 2008; 128: 371-377.
31. Silvia M, Agneta K, Erik M,. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005; 288: 1328-1338.
32. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98: 694-702. (Pubitemid 20069706)
33. Berg DJ, Davidson N, Kühn R, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest. 1996; 98: 1010-1020. (Pubitemid 26293320)
34. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell. 2004; 118: 229-241. (Pubitemid 38962578)
35. Pasare C, Medzhitov R,. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005; 560: 11-18.
36. Rakoff-Nahoum S, Medzhitov R,. Role of the innate immune system and host-commensal mutualism. Curr Top Microbiol Immunol. 2006; 308: 1-18. (Pubitemid 47400295)
37. Arvans DL, Vavricka SR, Ren H, et al. Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72. Am J Physiol Gastroenterol Liver Physiol. 2004; 288: G696-704.
38. Liu N, Nguyen L, Chun RF, et al. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology. 2008; 149: 4799-4808.
39. Yan Y, Kolachala V, Dalmasso G, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One. 2009; 29; 4: e6073.
40. Seth A, Yan F, Polk DB, et al. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G1060-G1069. (Pubitemid 351520059)
41. Johnson-Henry KC, Donato KA, Shen-Tu G, et al. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun. 2008; 76: 1340-1348. (Pubitemid 351561979)
42. Otte JM, Podolsky DK,. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004; 286: G613-G626. (Pubitemid 38374981)
43. Cook R, Wu CC, Kang YJ, et al. The role of the p38 pathway in adaptive immunity. Cell Mol Immunol. 2007; 4: 253-259.
44. Araki A, Kanai T, Ishikura T, et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol. 2005; 40: 16-23. (Pubitemid 40796328)
45. Panwala CM, Jones JC, Viney JL,. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol. 1998; 161: 5733-5744. (Pubitemid 28519142)
46. Schwab M, Schaeffeler E, Marx C, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 2003; 124: 26-33. (Pubitemid 36055335)
47. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004; 36: 471-475. (Pubitemid 38620030)
48. Yan F, Cao H, Cover TL, et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology. 2007; 132: 562-575. (Pubitemid 46274659)
49. Bouwmeester T, Bauch A, Ruffner H, et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol. 2004; 6: 97-105. (Pubitemid 38425708)
50. Duff G,. Immune diseases. Many roles for interleukin-1. Nature. 1985; 313: 352-353. (Pubitemid 15198717)
51. Neish AS, Gewirtz AT, Zeng H, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 2000; 289: 1560-1563.
52. Christensen HR, Frokiaer H, Pestka JJ,. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002; 168: 171-178. (Pubitemid 34014116)
53. Ruiz PA, Hoffmann M, Szcesny S, et al. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology. 2005; 115: 441-450. (Pubitemid 41032432)
54. Lin YP, Thibodeaux CH, Pena JA, et al. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis. 2008; 14: 1068-1083.
55. Chen LL, Wang XH, Cui Y, et al. Therapeutic effects of four strains of probiotics on experimental colitis in mice. World J Gastroenterol. 2009; 15: 321-327.
56. Yeganegi M, Watson CS, Martins A, et al. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor. Am J Obstet Gynecol. 2009; 200: 532.e1-8.
57. Li N, Russell WM, Douglas-Escobar M, et al. Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res. 2009; 66: 203-207.
58. Schmidt EG, Claesson MH, Jensen SS, et al. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity. Inflamm Bowel Dis. 2010; 16: 390-400.
59. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005; 201: 233-240. (Pubitemid 40189432)
60. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006; 116: 1310-1316.
61. Haller D, Bode C, Hammes WP, et al. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut. 2000; 47: 79-87. (Pubitemid 30430415)
62. Fujii T, Ohtsuka Y, Lee T, et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad 7 expression in preterm infants. J Pediatr Gastroenterol Nutr. 2006; 43: 83-88. (Pubitemid 44022391)
63. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004; 53: 1602-1609. (Pubitemid 39434103)
64. von der Weid T, Bulliard C, Schiffrin EJ,. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol. 2001; 8: 695-701. (Pubitemid 32613693)
65. Baba N, Samson S, Bourdet-Sicard R, et al. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol. 2008; 84: 468-476.